Cite
HARVARD Citation
Zhang, D. et al. (2022). Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis. European respiratory journal. 60 (6), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhang, D. et al. (2022). Utility of whole genome sequencing in assessing risk and clinically relevant outcomes for pulmonary fibrosis. European respiratory journal. 60 (6), p. . [Online].